Lamzede Injection, Powder, Lyophilized, For Solution
Product Images NDC 10122-180

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lamzede (NDC 10122-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chiesi Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelprinciple Display Panel – 1 Vial Cartonndc 10122-180-02rx Onlylamzede® Velmanasealfa-tycvfor Injection10 mg Per Vialfor Intravenous Infusion After Reconstitution 1 X 10mg Single-dose Vialdiscard Unused Portion. (Lamzede Velmanase Alfa Tycv 01)

Packaging label for Lamzede (velmanase alfa-tycv) injection, powder, lyophilized for solution, 10 mg per vial. The label indicates it is for intravenous infusion after reconstitution and contains one single-dose vial. Manufactured by Chiesi Farmaceutici S.p.A., distributed by Chiesi USA, Inc., with storage and preparation instructions included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.